Eric Poma
Chief Executive Officer en MOLECULAR TEMPLATES, INC. .
Fortuna: 41 456 $ al 31/03/2024
Perfil
Eric E.
Poma is the founder of Molecular Templates, Inc. (founded in 2000) where he holds the title of Director, Chief Executive & Scientific Officer.
He is currently the Chief Executive Officer & Director at Molecular Templates OpCo, Inc. Dr. Poma's former positions include Vice President-Business Development at ImClone LLC (2001-2013) and Secretary & Vice President-Business Development at Innovive Pharmaceuticals, Inc. (2009-2013).
Dr. Poma's education history includes an undergraduate and doctorate degree from The University of North Carolina at Charlotte and an MBA from The Leonard N Stern School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/01/2024 | 18 507 ( 0.34% ) | 41 456 $ | 31/03/2024 |
Cargos activos de Eric Poma
| Empresas | Cargo | Inicio |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Chief Executive Officer | 01/01/2000 |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Chief Executive Officer | - |
Antiguos cargos conocidos de Eric Poma.
| Empresas | Cargo | Fin |
|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Corporate Officer/Principal | - |
Formación de Eric Poma.
| The University of North Carolina at Charlotte | Doctorate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
- Bolsa de valores
- Insiders
- Eric Poma
